← Eichor
Study identifier: NCT06967701 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

Condition: Type 1 Diabetes (T1D) · Latent Autoimmune Diabetes in Adult (LADA) · Pancreatitis  ·  Sponsor: Yale University

PhaseNA
Planned participants60
Who can joinAll sexes, 30 Years to 65 Years
Healthy volunteersNo

About this study

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This remote participation-based research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently. You do not need to live in Connecticut to participate, as there will be no required in-person visits during the study.

This description comes directly from the study's public registry record.

Talk to the study team

Yashvi Verma, BS  ·  203-444-0678  ·  activity@yale.edu

Garrett Ash, PhD, CSCS  ·  203-444-3079  ·  garrett.ash@yale.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Yale School of MedicineNew Haven, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06967701